FINWIRES · TerminalLIVE
FINWIRES

Apple Beats Second-Quarter Views Amid iPhone Strength

作者

-- Apple (AAPL) reported fiscal second-quarter results above Wall Street's estimates as iPhone revenue came in stronger than expected.

Per-share earnings rose to $2.01 for the quarter ended March 28 from $1.65 a year earlier, compared with the FactSet-polled consensus of $1.95. Net sales climbed 17% to $111.18 billion, ahead of the Street's $109.46 billion view.

"Continued strong customer demand for our products and services once again helped us achieve a new all-time high for our installed base of active devices across all major product categories and geographic segments," Chief Financial Officer Kevan Parekh said in a statement.

Sales for iPhone rallied to $56.99 billion from $46.84 billion in the year-earlier quarter. Analysts polled by FactSet had forecast $56.50 billion.

"IPhone achieved a March quarter revenue record, fueled by such extraordinary demand for the iPhone 17 lineup," Chief Executive Tim Cook said.

Earlier this month, the technology giant announced that insider John Ternus will become CEO in September, replacing Cook, who is set to take on the executive chairman role.

Wedbush Securities expected "strong results," saying Wall Street underestimates Apple's growth potential in 2026, ahead of its key artificial intelligence strategy launch at the Worldwide Developers Conference in June.

IPad revenue rose to $6.91 billion from $6.40 billion, while Mac jumped to $8.40 billion from $7.95 billion, Apple said.

Overall product sales advanced to $80.21 billion from $68.71 billion, while services increased to $30.98 billion from $26.65 billion. Consolidated revenue gained by double digits across every geographic segment year-over-year, Cook said.

Shares edged 0.5% lower in after-hours trading.

相關文章

Asia

盛和資源第一季獲利飆升94%,營收成長13%

根據盛和資源(SHA:600392)週四在上海證券交易所發布的公告顯示,該公司第一季歸屬於股東的淨利潤同比增長94%,從去年同期的1.683億元人民幣增至3.273億元人民幣。 每股盈餘較去年同期成長0.1867元人民幣,高於去年同期的0.0960元。 這家中國稀土礦商的營業收入較去年同期成長13%,從去年同期的29.9億元增加到33.8億元。

$SHA:600392
Research

研究報告提醒:CFRA重申希爾頓全球控股公司股票的賣出評級

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們將12個月目標價上調9美元至293美元,相當於2026年每股盈餘預期(維持不變)的32倍,與該股五年平均遠期本益比一致。我們將2026年每股盈餘預期從8.88美元上調至9.16美元,並將2027年每股盈餘預期從10.20美元下調至10.03美元。鑑於第一季業績超出預期並上調了業績指引,我們維持2顆星(賣出)評級。美國每間可供出租客房收入(RevPAR)的成長範圍從主要來自豪華和高端市場擴展到更多中端市場,管理層認為這得益於中低收入消費者的回歸。然而,我們注意到第一季業績也包括平均房價(ADR)成長放緩,尤其是在歷來貢獻顯著利潤的豪華飯店。 HLT第二季EBITDA預期為10.15億至10.35億美元,低於市場普遍預期的10.81億美元,顯示奢侈品定價權的減弱速度超過了中端市場銷售成長所能抵銷的幅度。儘管需求成長趨勢向好,但我們認為奢侈品市場利好因素的放緩限制了其在當前估值水準下的上漲空間。

$HLT
Research

研究快訊:CFRA維持對環球健康服務公司股票的買進評級

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下:我們將UHS的12個月目標價從243美元下調至200美元,相當於我們2026年每股收益預期的8.7倍,低於同業平均水平,也低於UHS五年曆史平均預期市盈率11.9倍。我們將2026年每股盈餘預期從23.39美元下調至22.95美元,並將2027年預期從25.67美元下調至25.48美元。第一季住院量與上一季持平,受到冬季惡劣天氣和流感/呼吸道疾病流行程度較輕等季節性不利因素的影響。 近期《平價醫療法案》(ACA)電子支付稅收抵免(EPTC)的到期也帶來了挑戰,UHS預計,與2025年第一季相比,ACA調整後的入院人數將下降近5%。 UHS維持了先前的預測,即全年ACA交易所的交易量將下降25%-30%,這約佔2025年急性護理業務調整後入院人數的6%,以及急性護理業務收入的不到5%。 UHS預計,這些因素將導致其2026年稅前利潤減少7,500萬美元,與先前的預期一致。

$UHS